Iohexol in lower extremity, renal and visceral angiography. Survey and present state.
In 15 reports concerning 516 patients subjected to visceral or peripheral angiography high quality angiographic films were obtained following injection of iohexol. Iohexol represents a major step forward with regard to patient discomfort compared with conventional ionic media. Some pain may occur in patients with severe arteriosclerotic disease. Iohexol was well tolerated in renal and visceral angiography. No clinically significant changes were observed in serum values of hepatic or pancreatic enzymes or electrolytes and no signs of renal injury reported in patients with normal kidney function.
D000792:Angiography / Q000379:methods*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000633:toxicity; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007463:Iodobenzoates; D007472:Iohexol; D007668:Kidney / Q000000981:diagnostic imaging*; D007866:Leg / Q000000981:diagnostic imaging*; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D011860:Radiography, Abdominal; D011897:Random Allocation; D014283:Triiodobenzoic Acids / Q000633:toxicity; D014581:Urticaria / Q000139:chemically induced; D014655:Vascular Resistance / Q000187:drug effects
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007472:Iohexol